New Drug and Technology Assessment in Bladder Cancer: Creation of a Novel Canadian Policy Model for Bladder Cancer
New Drug and Technology Assessment in Bladder Cancer: Creation of a Novel Canadian Policy Model for Bladder Cancer
膀胱癌新药物和技术评估：创建加拿大膀胱癌新政策模型
批准号：
379031
负责人：
Kulkarni Girish S
金额：
$7.29万
依托单位国家：
加拿大
项目类别：
Operating Grants
财政年份：
2017
资助国家：
加拿大
项目状态：
已结题
起止时间：
2017-10-01 至 2018-10-01
中文摘要
翻译
导言：膀胱癌（BCa）是目前治疗费用最高的癌症之一，随着许多有希望但昂贵的治疗方法的出现，BCa的治疗费用预计会进一步增加。因此，评估其影响的研究
英文摘要
Introduction: Bladder cancer (BCa) is currently one of the most expensive cancers to treat, and with many promising but costly therapies emerging, BCa treatment costs are expected to increase even further. As a result, research that assesses how to effect
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
New Drug and Technology Assessment in Bladder Cancer: Creation of a Novel Canadian Policy Model for Bladder Cancer
-
批准号：420558
-
项目类别：Operating Grants
-
资助金额：$49.54万
-
财政年份：2020
-
负责人：Kulkarni Girish S
-
依托单位：
海外基金
